{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:38:28Z","timestamp":1787164708551,"version":"build-2736575974"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mechanisms of Ageing and Development"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.mad.2023.111898","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T21:31:00Z","timestamp":1703799060000},"page":"111898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design"],"prefix":"10.1016","volume":"218","author":[{"given":"Tal","family":"Davidy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iscka","family":"Yore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Cukierman-Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramit","family":"Ravona-Springer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Livny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit H.","family":"Lesman-Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossi","family":"Azuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Kapogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HungMo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal Schnaider","family":"Beeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mad.2023.111898_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2021.101339","article-title":"Effects of monoclonal antibodies against amyloid-\u03b2 on clinical and biomarker outcomes and adverse event risks: a systematic review and meta-analysis of phase III RCTs in Alzheimer\u2019s disease","volume":"68","author":"Avgerinos","year":"2021","journal-title":"Ageing Res Rev."},{"issue":"4","key":"10.1016\/j.mad.2023.111898_bib2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/gerona\/glz073","article-title":"Computerized cognitive training for older adults at higher dementia risk due to diabetes: findings from a randomized controlled trial","volume":"75","author":"Bahar-Fuchs","year":"2020","journal-title":"J. Gerontol. - Ser. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.mad.2023.111898_bib3","doi-asserted-by":"crossref","unstructured":"Beeri M.S., Schmeidler J., Silverman J.M., et al. Insulin in combination with other diabetes medication is associated with less alzheimer neuropathology.; 2008.","DOI":"10.1212\/01.wnl.0000324925.95210.6d"},{"issue":"6","key":"10.1016\/j.mad.2023.111898_bib4","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jalz.2014.06.002","article-title":"The Israel diabetes and cognitive decline (IDCD) study: design and baseline characteristics","volume":"10","author":"Beeri","year":"2014","journal-title":"Alzheimer\u2019s Dement."},{"issue":"1","key":"10.1016\/j.mad.2023.111898_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3233\/JAD-170402","article-title":"Intracranial arterial 4D flow in individuals with mild cognitive impairment is associated with cognitive performance and amyloid positivity","volume":"60","author":"Berman","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"issue":"2","key":"10.1016\/j.mad.2023.111898_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00330-015-3834-9","article-title":"Cerebral perfusion in the predementia stages of Alzheimer\u2019s disease","volume":"26","author":"Binnewijzend","year":"2016","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.mad.2023.111898_bib7","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.20170","article-title":"Low cerebral blood flow is associated with lower memory function in metabolic syndrome","volume":"21","author":"Birdsill","year":"2013","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.mad.2023.111898_bib8","first-page":"676","article-title":"Hyperuricemia and metabolic syndrome: lessons from a large cohort in Israel","volume":"14","author":"Cohen","year":"2012","journal-title":"IMAJ-Isr. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.mad.2023.111898_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"issue":"1","key":"10.1016\/j.mad.2023.111898_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch. Neurol."},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib12","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","article-title":"Safety, efficacy, and feasibility of intranasal insulin for the reatment of mild cognitive impairment and alzheimer disease dementia: a randomized clinical trial","volume":"77","author":"Craft","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.mad.2023.111898_bib14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.trci.2018.02.005","article-title":"Virtual reality-based cognitive-motor training for middle-aged adults at high Alzheimer\u2019s disease risk: A randomized controlled trial","volume":"4","author":"Doniger","year":"2018","journal-title":"Alzheimer\u2019s Dement.: Transl. Res. Clin. Interv."},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib15","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med"},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib16","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat. Med"},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib17","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/alz.12130","article-title":"Extracellular vesicle biomarkers of Alzheimer\u2019s disease associated with sub-clinical cognitive decline in late middle age","volume":"16","author":"Eren","year":"2020","journal-title":"Alzheimer\u2019s Dement."},{"issue":"1","key":"10.1016\/j.mad.2023.111898_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-019-3259-x","article-title":"Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer\u2019s disease: Study protocol for a randomised controlled trial (ELAD study)","volume":"20","author":"Femminella","year":"2019","journal-title":"Trials"},{"issue":"10193","key":"10.1016\/j.mad.2023.111898_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"10193","key":"10.1016\/j.mad.2023.111898_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mad.2023.111898_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(19)30423-1","article-title":"The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial","volume":"8","author":"Gerstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.mad.2023.111898_bib22","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/j.1460-9568.1995.tb00650.x","article-title":"Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites","volume":"7","author":"G\u00f6ke","year":"1995","journal-title":"Eur. J. Neurosci."},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib23","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.mad.2023.111898_bib24","unstructured":"Graf C., Eckstein CBE. 2.5HOURS. Vol 108.; 2008. http:\/\/www.nursingcenter.com."},{"issue":"3","key":"10.1016\/j.mad.2023.111898_bib25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/gps.4008","article-title":"Age, gender, and education are associated with cognitive performance in an older Israeli sample with type 2 diabetes","volume":"29","author":"Guerrero-Berroa","year":"2014","journal-title":"Int J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.mad.2023.111898_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.ijo.0803722","article-title":"Obese men respond to cognitive but not to catabolic brain insulin signaling","volume":"32","author":"Hallschmid","year":"2008","journal-title":"Int. J. Obes."},{"issue":"3","key":"10.1016\/j.mad.2023.111898_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/bjsports-2016-096846","article-title":"Aerobic exercise promotes executive functions and impacts functional neural activity among older adults with vascular cognitive impairment","volume":"52","author":"Hsu","year":"2018","journal-title":"Br. J. Sports Med."},{"key":"10.1016\/j.mad.2023.111898_bib28","doi-asserted-by":"crossref","unstructured":"Isomaa B.O., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Accessed October 25, 2022. http:\/\/diabetesjournals.org\/care\/article-pdf\/24\/4\/683\/587730\/683.pdf.","DOI":"10.2337\/diacare.24.4.683"},{"issue":"11","key":"10.1016\/j.mad.2023.111898_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206547","article-title":"Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer\u2019s disease and normalized by treatment with anti-diabetic agents","volume":"13","author":"Katsel","year":"2018","journal-title":"PLOS One"},{"issue":"3","key":"10.1016\/j.mad.2023.111898_bib30","doi-asserted-by":"crossref","first-page":"240","DOI":"10.14283\/jpad.2021.14","article-title":"Intranasal insulin reduces white matter hyperintensity progression in association with improvements in cognition and CSF biomarker profiles in mild cognitive impairment and alzheimer\u2019s disease","volume":"8","author":"Kellar","year":"2021","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"issue":"8","key":"10.1016\/j.mad.2023.111898_bib31","first-page":"566","article-title":"Development of a Hebrew questionnaire to be used in epidemiological studies to assess physical fitness--validation against sub maximal stress test and predicted VO2max","volume":"143","author":"Ken-Dror","year":"2004","journal-title":"Harefuah"},{"key":"10.1016\/j.mad.2023.111898_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00927","article-title":"Cerebral small vessel disease and Alzheimer\u2019s disease: a review","volume":"11","author":"Kim","year":"2020","journal-title":"Front Neurol."},{"issue":"21","key":"10.1016\/j.mad.2023.111898_bib33","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.mad.2023.111898_bib34","article-title":"Cerebrovascular insulin receptors are defective in Alzheimer\u2019s disease","author":"Leclerc","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.mad.2023.111898_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110605","article-title":"Efficacy and safety of oral semaglutide in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"198","author":"Li","year":"2023","journal-title":"Diabetes Res Clin. Pr."},{"issue":"5","key":"10.1016\/j.mad.2023.111898_bib36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer\u2019s disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.mad.2023.111898_bib37","doi-asserted-by":"crossref","unstructured":"Memphis)Cukierman-Yaffe T., Gerstein H.C., et al. Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial. Vol 19.; 2020. ww.thelancet.com\/neurology.","DOI":"10.1016\/S1474-4422(20)30173-3"},{"key":"10.1016\/j.mad.2023.111898_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neurobiolaging.2016.03.026","article-title":"Age-dependent differences in brain tissue microstructure assessed with neurite orientation dispersion and density imaging","volume":"43","author":"Merluzzi","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mad.2023.111898_bib39","doi-asserted-by":"crossref","unstructured":"Morris J.C., Ernesto; C., Schafer; K., et al. Articles-clinical dementia rating training and reliability in multicenter studies: the Alzheimer\u2019s disease cooperative study experience.; 1997.","DOI":"10.1212\/WNL.48.6.1508"},{"issue":"4","key":"10.1016\/j.mad.2023.111898_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: a double-blinded placebo-controlled pilot study","volume":"14","author":"Novak","year":"2019","journal-title":"PLOS One"},{"issue":"4","key":"10.1016\/j.mad.2023.111898_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: a double-blinded placebo-controlled pilot study","volume":"14","author":"Novak","year":"2019","journal-title":"PLOS One"},{"issue":"4","key":"10.1016\/j.mad.2023.111898_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214364","article-title":"Safety and preliminary efficacy of intranasal insulin for cognitive impairment in Parkinson disease and multiple system atrophy: a double-blinded placebo-controlled pilot study","volume":"14","author":"Novak","year":"2019","journal-title":"PLOS One"},{"issue":"1","key":"10.1016\/j.mad.2023.111898_bib43","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/2516043520972861","article-title":"A Likert-type scale for evaluating the \u201cbottom line\u201d of patient safety","volume":"26","author":"Rashkovits","year":"2021","journal-title":"J. Patient Saf. Risk Anag."},{"issue":"2","key":"10.1016\/j.mad.2023.111898_bib44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JAD-200623","article-title":"The Israel registry for alzheimer\u2019s prevention (IRAP) study: design and baseline characteristics","volume":"78","author":"Ravona-Springer","year":"2020","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.mad.2023.111898_bib45","doi-asserted-by":"crossref","unstructured":"Reger M.A., Watson G.S., Green P.S., et al. Intranasal insulin administration dose-dependently modulates verbal memory and plasma \u03b2-amyloid in memory-impaired older adults NIH public access. Vol 13.; 2008.","DOI":"10.3233\/JAD-2008-13309"},{"issue":"4","key":"10.1016\/j.mad.2023.111898_bib46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12031-019-1257-9","article-title":"Combination of insulin with a GLP1 agonist is associated with better memory and normal expression of insulin receptor pathway genes in a mouse model of alzheimer\u2019s disease","volume":"67","author":"Robinson","year":"2019","journal-title":"J. Mol. Neurosci."},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib47","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1073\/pnas.0809148106","article-title":"Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias","volume":"106","author":"Sato","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib48","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1073\/pnas.0809148106","article-title":"Synchronization of chaotic early afterdepolarizations in the genesis of cardiac arrhythmias","volume":"106","author":"Sato","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.mad.2023.111898_bib49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","article-title":"Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with alzheimer disease","volume":"10","author":"Shoghi-Jadid","year":"2002","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.mad.2023.111898_bib50","article-title":"Safety of Semaglutide","volume":"12","author":"Smits","year":"2021","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.mad.2023.111898_bib51","unstructured":"Stamm B.H.. The Concise ProQOL Manual.; 2010."},{"issue":"9","key":"10.1016\/j.mad.2023.111898_bib52","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1111\/dom.13331","article-title":"Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1-5 trials","volume":"20","author":"Warren","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.mad.2023.111898_bib53","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1047-2797(02)00464-7","article-title":"Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study","volume":"13","author":"Wu","year":"2003","journal-title":"Ann. Epidemiol."}],"container-title":["Mechanisms of Ageing and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637423001240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0047637423001240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:51:25Z","timestamp":1758649885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0047637423001240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":53,"alternative-id":["S0047637423001240"],"URL":"https:\/\/doi.org\/10.1016\/j.mad.2023.111898","relation":{},"ISSN":["0047-6374"],"issn-type":[{"value":"0047-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A feasibility study of the combination of intranasal insulin with oral semaglutide for cognition in older adults with metabolic syndrome at high dementia risk- Study rationale and design","name":"articletitle","label":"Article Title"},{"value":"Mechanisms of Ageing and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mad.2023.111898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111898"}}